SMMT peer analysis
Summit Therapeutics (SMMT) against its competitors: price, today's move, 1-year return and market value side by side.
SMMT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACXP Acurx Pharmaceuticals | $1.04 | -2.80% | -79.61% | – |
| ENTA Enanta Pharmaceuticals | $10.71 | -3.95% | -1.38% | $311.93M |
| IBRX ImmunityBio | $7.94 | -4.22% | 236.44% | $8.79B |
| MCRB Seres Therapeutics | $1.77 | -9.23% | -88.78% | $17.78M |
| PALI Palisade Bio | $1.16 | -2.52% | -40.21% | – |
| SPRO Spero Therapeutics | $1.06 | -4.50% | -55.08% | $61.73M |
| TRAW Traws Pharma | $0.30 | -1.66% | -88.79% | – |
| SMMT Summit Therapeutics | $15.00 | -6.43% | -19.53% | $12.79B |
- SMMT's peers: ACXP (Acurx Pharmaceuticals), ENTA (Enanta Pharmaceuticals), IBRX (ImmunityBio), MCRB (Seres Therapeutics), PALI (Palisade Bio), SPRO (Spero Therapeutics), TRAW (Traws Pharma).
Updated 2026-11-03 02:03 UTC